CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade MerckCo USA MRK

MerckCo live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

MerckCo news

N/A
Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

N/A
Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Neil Wilson 2024 Oct 24, 16:00

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Forex Indices
Bank of England, BoJ, Fed all hold policy meetings this week
Georgy Istigechev 2024 Jul 25, 16:00

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Forex Indices
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
The Bank of England
Neil Wilson 2024 Jan 25, 08:03

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares

Latest news

Show more
Ghko B 2025 Jul 03, 16:00

Solana Price Gains 4%: What is the price target for Solana?

Cryptocurrencies
Frances Wang 2025 Jul 03, 16:00

Bitcoin Price Outlook: What will be the value of Bitcoin in 2025?

Cryptocurrencies
Tommy Yap 2025 Jul 03, 16:00

Morning Note: Markets Break Records - What’s Fueling the Surge?

Morning Note Stocks S&P 500 Forex Oil CPI
N/A
Noah Lee 2025 Jul 03, 08:35

Wall Street Strategist: Potential $100B+ Stock Market Influx Coming

N/A
Sophia Claire 2025 Jul 03, 08:35

Euro Surges in Foreign Exchange Options Market Amid Bullish Sentiment

N/A
Emma Rose 2025 Jul 03, 08:35

AI Podcast: The Pennsylvania Plan - Domestic Investors to the Rescue?

N/A
liam james 2025 Jul 03, 08:35

AI Podcast: Dollar Weakens Amid Fed Chair Uncertainty

N/A
liam james 2025 Jul 03, 08:35

JPMorgan Model Predicts Stock Market Upswing: An AI Podcast Breakdown

Info

Spread

0.49

Spread (%)

0.6071 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-16:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

206883766272

Shares Outstanding

2511030016

Earnings Date (Next)

2021-06-03

Div Yield

2025-07-08

Ex-Dividend Date

2025-06-16

Forward annual dividend rate

3.24

Forward annual dividend yield

0.0409

EPS

6.88

Learn more about this instrument

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Jul 03, 16:00

DJT Stock CFD Trading: Trump Media & Technology Group CFDs Introduction

Stocks CFD Trading
Ghko B 2025 Jul 03, 16:00

TSLA Online CFD Trading: Sell and buy TSLA CFDs with markets.com

Stocks CFD Trading
Ghko B 2025 Jul 03, 16:00

Cardano (ADA) Price Prediction: Can Cardano Hit $0.70 in July?

Crypto
Trustpilot